A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer.
Choi DR, Yoon SN, Kim HS, Kim JH, Kim KY, Kim BC, Choi YK, Kim JB, Han B, Song HH, Zang DY.
Choi DR, et al. Among authors: kim bc, kim jb, kim hs, kim jh, kim ky.
Cancer Chemother Pharmacol. 2015 Mar;75(3):639-43. doi: 10.1007/s00280-015-2688-9. Epub 2015 Jan 29.
Cancer Chemother Pharmacol. 2015.
PMID: 25630415
Clinical Trial.